StreetInsider.com News Articles

Form 8-K Q/C TECHNOLOGIES, INC. For: Sep 22

Fri, 26 Sep 2025 17:11:00 -0400

si-local-file:///var/storage/secattach/20250926/25385505.html

Form 8-K Q/C TECHNOLOGIES, INC. For: Sep 22

Fri, 26 Sep 2025 17:11:00 -0400

si-local-file:///var/storage/secattach/20250926/25385505.html

Form 8-K Q/C TECHNOLOGIES, INC. For: Sep 22

Fri, 26 Sep 2025 17:11:00 -0400

si-local-file:///var/storage/secattach/20250926/25385505.html

Q/C Technologies begins trading on NASDAQ under ticker QCLS

Thu, 25 Sep 2025 09:15:32 -0400

Q/C Technologies, Inc. (NASDAQ: QCLS) commenced trading under its new ticker symbol today, following its name change from TNF Pharmaceuticals, Inc. The company announced the transition reflects its strategic pivot into quantum-class computing.

The company holds exclusive global rights to LightSolver's light-speed laser processing unit for cryptocurrency applications. The technology represents what the company describes as a light and laser-based computing system.

"The official transition to Q/C Technologies and our new Nasdaq ticker is an important milestone in aligning our public identity with the Company's transformation," said Joshua Silverman, Executive Chairman of Q/C Technologies.

Current shareholders require no action in connection with the

Q/C Technologies begins trading on NASDAQ under ticker QCLS

Thu, 25 Sep 2025 09:15:32 -0400

Current shareholders require no action in connection with the

Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol “QCLS”

Thu, 25 Sep 2025 09:15:00 -0400

Licensed technology positions Company at forefront of new quantum-class computing paradigm

NEW YORK--(BUSINESS WIRE)-- Q/C Technologies, Inc. (Nasdaq: QCLS), formerly TNF Pharmaceuticals, Inc. (Nasdaq: TNFA), (“Q/C” or “the Company”), today announced that its common stock will begin trading under the new ticker symbol “QCLS” beginning today at the market open.

The Company’s new name Q/C Technologies represents its recent strategic pivot into quantum-class computing with exclusive global rights to LightSolver’s light-speed laser processing unit (LPU), the world’s first light and laser-based computing system, for application in quantum class cryptocurrency verticals.

“The official transition to Q/C Technologies and our new

Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol “QCLS”

Thu, 25 Sep 2025 09:15:00 -0400

Licensed technology positions Company at forefront of new quantum-class computing paradigm

“The official transition to Q/C Technologies and our new

Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol “QCLS”

Thu, 25 Sep 2025 09:15:00 -0400

Licensed technology positions Company at forefront of new quantum-class computing paradigm

“The official transition to Q/C Technologies and our new

Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol “QCLS”

Thu, 25 Sep 2025 09:15:00 -0400

Licensed technology positions Company at forefront of new quantum-class computing paradigm

“The official transition to Q/C Technologies and our new

Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol “QCLS”

Thu, 25 Sep 2025 09:15:00 -0400

Licensed technology positions Company at forefront of new quantum-class computing paradigm

“The official transition to Q/C Technologies and our new

Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol “QCLS”

Thu, 25 Sep 2025 09:15:00 -0400

Licensed technology positions Company at forefront of new quantum-class computing paradigm

“The official transition to Q/C Technologies and our new

TNF Pharmaceuticals changes name to Q/C Technologies, new ticker QCLS

Wed, 24 Sep 2025 09:15:15 -0400

TNF Pharmaceuticals Inc. (NASDAQ: TNFA) announced it will change its corporate name to Q/C Technologies Inc. and begin trading under the ticker symbol "QCLS" on the Nasdaq Capital Market starting September 25, 2025.

The name change reflects the company's shift from pharmaceuticals to quantum-class computing technology. Q/C Technologies has obtained exclusive global rights to use LightSolver's light-speed laser processing unit technology in the cryptocurrency sector.

According to the company's press release, the laser processing units use light-based computing and can reduce energy consumption by up to 90% compared to traditional systems. The technology is designed for blockchain operations in the cryptocurrency industry.

"Our

TNF Pharmaceuticals changes name to Q/C Technologies, new ticker QCLS

Wed, 24 Sep 2025 09:15:15 -0400

"Our

TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol “QCLS” to Reflect Strategic Focus on Quantum Class Photonic Computing

Wed, 24 Sep 2025 09:15:00 -0400

New trading symbol QCLS effective Thursday, September 25, 2025

Licensed technology positions Company at forefront of new quantum-class computing paradigm

NEW YORK--(BUSINESS WIRE)-- TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“Q/C” or the “Company”) today announced that it has changed its corporate name to Q/C Technologies, Inc. and will begin trading under the new ticker symbol “QCLS” on the Nasdaq Capital Market, effective as of the market open on Thursday, September 25, 2025. Until then, the Company’s common stock will continue to trade under its current ticker symbol “TNFA.”

The new name Q/C Technologies represents the Company’s recent strategic pivot

TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol “QCLS” to Reflect Strategic Focus on Quantum Class Photonic Computing

Wed, 24 Sep 2025 09:15:00 -0400

New trading symbol QCLS effective Thursday, September 25, 2025

Licensed technology positions Company at forefront of new quantum-class computing paradigm

The new name Q/C Technologies represents the Company’s recent strategic pivot

TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol “QCLS” to Reflect Strategic Focus on Quantum Class Photonic Computing

Wed, 24 Sep 2025 09:15:00 -0400

New trading symbol QCLS effective Thursday, September 25, 2025

Licensed technology positions Company at forefront of new quantum-class computing paradigm

The new name Q/C Technologies represents the Company’s recent strategic pivot

TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol “QCLS” to Reflect Strategic Focus on Quantum Class Photonic Computing

Wed, 24 Sep 2025 09:15:00 -0400

New trading symbol QCLS effective Thursday, September 25, 2025

Licensed technology positions Company at forefront of new quantum-class computing paradigm

The new name Q/C Technologies represents the Company’s recent strategic pivot

TNF Pharmaceuticals regains NASDAQ minimum bid price compliance

Wed, 17 Sep 2025 09:24:12 -0400

TNF Pharmaceuticals Inc. (NASDAQ: TNFA) received written notice from the Nasdaq Stock Market on September 16, 2025, confirming the company has regained compliance with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).

The company's shares maintained the minimum bid price of $1.00 for 10 consecutive business days to meet the compliance requirement, according to the press release statement.

"We are pleased to have regained compliance with Nasdaq's listing standards," said Joshua Silverman, Executive Chairman. "This milestone comes as we work to build a strong strategic platform for growth and shareholder value."

The announcement addresses the company's previous non-compliance with Nasdaq's

TNF Pharmaceuticals regains NASDAQ minimum bid price compliance

Wed, 17 Sep 2025 09:24:12 -0400

The company's shares maintained the minimum bid price of $1.00 for 10 consecutive business days to meet the compliance requirement, according to the press release statement.

The announcement addresses the company's previous non-compliance with Nasdaq's

TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

Wed, 17 Sep 2025 09:24:00 -0400

NEW YORK--(BUSINESS WIRE)-- TNF Pharmaceuticals Inc. (Nasdaq: TNFA), (“TNF” or the “Company”) today announced that it received written notice from the Nasdaq Stock Market on September 16, 2025, confirming that the Company has regained compliance with Nasdaq’s $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550 (a)(2). To regain compliance with the Listing Rule, the Company’s shares maintained the minimum bid price of $1.00 for 10 consecutive business days.

"We are pleased to have regained compliance with Nasdaq’s listing standards. This milestone comes as we work to build a strong strategic platform for growth and shareholder value.

TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

Wed, 17 Sep 2025 09:24:00 -0400

"We are pleased to have regained compliance with Nasdaq’s listing standards. This milestone comes as we work to build a strong strategic platform for growth and shareholder value.

TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

Wed, 17 Sep 2025 09:24:00 -0400

"We are pleased to have regained compliance with Nasdaq’s listing standards. This milestone comes as we work to build a strong strategic platform for growth and shareholder value.

TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

Wed, 17 Sep 2025 09:24:00 -0400

"We are pleased to have regained compliance with Nasdaq’s listing standards. This milestone comes as we work to build a strong strategic platform for growth and shareholder value.

Form 8-K TNF Pharmaceuticals, For: Sep 04

Wed, 10 Sep 2025 17:01:00 -0400

si-local-file:///var/storage/secattach/20250910/25321396.html

Form 8-K TNF Pharmaceuticals, For: Sep 04

Wed, 10 Sep 2025 17:01:00 -0400

si-local-file:///var/storage/secattach/20250910/25321396.html